AmpliPhi Biosciencess C3J Logo

Armata has joined together two seasoned drug development teams, AmpliPhi Biosciences and C3J Therapeutics, to tackle the global and increasingly serious threat of antimicrobial-resistant bacterial infections. Driven by rigorous and innovative science, Armata is developing high-impact, best-in-class bacteriophage therapeutics with the potential to save millions of lives.

Armata Pharmaceuticals
Enter

Board of Directors

Richard Bastiani, Ph.D.
Chairman
Read Bio »
Richard Bear
Director
Read Bio »
Jeremy Curnock Cook
Director
Read Bio »
H. Stewart Parker
Director
Read Bio »
Todd R. Patrick
CEO, Director
Read Bio »
Joseph M. Patti, Ph.D.
Director
Read Bio »
Michael S. Perry, D.V.M., Ph.D.
Director
Read Bio »
Todd C. Peterson, Ph.D.
Director
Read Bio »